cnbc
Trump's tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
CNBC • 1 YEAR AGO
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
CNBC • 1 YEAR AGO
This All-Weather stock list is outperforming in this tough market — here's another new idea
CNBC • 1 YEAR AGO
Cliff Asness's AQR multi-strategy hedge fund returns 9% in the first quarter during tough conditions
CNBC • 1 YEAR AGO
